Ligand Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-	-33.36	57.14	-2.99	629.3	143.32	12.56	-1.64	229.82	12.02	Upgrade
Depreciation & Amortization	37.38	56.89	55.79	29.58	43.73	14.72	11.71	11.29	2.63	2.66	Upgrade
Share-Based Compensation	25.74	60.29	38.78	30.73	24.52	17.08	24.92	17.89	12.46	11.27	Upgrade
Other Operating Activities	-13.54	54.04	-72.91	-2.73	-726.88	18.94	39.39	33.19	-203.18	-5.39	Upgrade
Operating Cash Flow	49.58	137.85	78.8	54.59	-29.34	194.06	88.57	60.73	41.73	20.57	Upgrade
Operating Cash Flow Growth	-64.04%	74.94%	44.36%	-	-	119.10%	45.84%	45.55%	102.89%	-0.60%	Upgrade
Capital Expenditures	-53.43	-17.83	-8.27	-3.1	-2.55	-10.89	4.9	-19.55	-4.12	-1.01	Upgrade
Acquisitions	-25.65	-0.75	0	-382.82	-11.84	-1.97	-26.45	-99.41	-15.99	-3.49	Upgrade
Change in Investments	67.4	183.17	40.01	615.67	-326.82	-409.44	-57.62	-21.97	-92.75	2.34	Upgrade
Other Investing Activities	-	-0.96	-1.22	1.9	808.13	-0.98	-	6.51	-	0.13	Upgrade
Investing Cash Flow	-11.68	163.62	30.52	231.65	466.92	-423.27	-79.18	-134.42	-112.86	-2.03	Upgrade
Share Issuance / Repurchase	22.45	3.23	33.76	-74.98	-450.05	-12.69	2.55	2.51	8.36	-51.76	Upgrade
Debt Issued / Paid	-77.85	-260.8	-146.01	-231.76	-27.32	515.4	0	0	0	229.92	Upgrade
Other Financing Activities	-4.55	-16.88	-6.02	-3.81	-7.8	-174.13	-10.07	-7.51	-	-48.14	Upgrade
Financing Cash Flow	-59.95	-274.45	-118.27	-310.55	-485.17	328.59	-7.52	-4.99	8.36	130.03	Upgrade
Exchange Rate Effect	-	0	0	0	0.08	-0.22	0	0	0	0	Upgrade
Net Cash Flow	0	0	0	-24.31	-47.59	99.38	1.87	-78.68	-62.78	148.56	Upgrade
Free Cash Flow	-3.85	120.02	70.53	51.49	-31.89	183.17	93.47	41.19	37.6	19.56	Upgrade
Free Cash Flow Growth	-	70.16%	36.99%	-	-	95.97%	126.93%	9.53%	92.25%	16.83%	Upgrade
Free Cash Flow Margin	-	61.16%	29.20%	31.48%	-26.51%	72.85%	66.24%	37.80%	52.29%	30.31%	Upgrade
Free Cash Flow Per Share	-0.22	7.12	4.24	3.18	-1.68	8.66	4.44	1.98	1.90	0.96	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).